Detalles de la búsqueda
1.
Ferumoxytol for iron deficiency anemia in patients undergoing hemodialysis. The FACT randomized controlled trialâ©.
Clin Nephrol
; 91(4): 237-245, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30802204
2.
Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: A randomized trial.
Am J Hematol
; 93(5): 683-690, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29417614
3.
Correction to: The Ferumoxytol for Anemia of CKD Trial (FACT)-a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale.
BMC Nephrol
; 19(1): 97, 2018 04 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-29699506
4.
The Ferumoxytol for Anemia of CKD Trial (FACT)-a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale.
BMC Nephrol
; 18(1): 117, 2017 04 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28372549
5.
A response by Strauss et al. to "a comment on the comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia".
Am J Hematol
; 93(9): E232-E233, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30016554
6.
Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open-label, 6-month extension study.
Am J Hematol
; 91(2): E3-5, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26572233
7.
Intravenous Iron-Induced Hypophosphatemia: An Emerging Syndrome.
Adv Ther
; 38(7): 3531-3549, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34053011
8.
Hypophosphatemia Associated with Intravenous Iron Therapies for Iron Deficiency Anemia: A Systematic Literature Review.
Ther Clin Risk Manag
; 16: 245-259, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32308402
9.
Health-related quality of life in patients with iron deficiency anemia: impact of treatment with intravenous iron.
Patient Relat Outcome Meas
; 9: 285-298, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30214332
10.
Cost-effectiveness analysis of intravenous ferumoxytol for the treatment of iron deficiency anemia in adult patients with non-dialysis-dependent chronic kidney disease in the USA.
Clinicoecon Outcomes Res
; 9: 557-567, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29033594
11.
Comparative safety of intravenous Ferumoxytol versus Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia: rationale and study design of a randomized double-blind study with a focus on acute hypersensitivity reactions.
J Blood Med
; 8: 155-163, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29033620
12.
Efficacy and safety of IV ferumoxytol for iron deficiency anemia in patients with cancer.
J Blood Med
; 8: 199-209, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29263710
13.
Ferumoxytol versus iron sucrose treatment: a post-hoc analysis of randomized controlled trials in patients with varying renal function and iron deficiency anemia.
BMC Hematol
; 16: 20, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27462400
14.
Ferumoxytol versus placebo in iron deficiency anemia: efficacy, safety, and quality of life in patients with gastrointestinal disorders.
Clin Exp Gastroenterol
; 9: 151-62, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27468245
15.
A randomized comparison of ferumoxytol and iron sucrose for treating iron deficiency anemia in patients with CKD.
Clin J Am Soc Nephrol
; 9(4): 705-12, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24458078
16.
One-year outcomes from the TAXUS express stent versus cypher stent.
Am J Cardiol
; 103(7): 930-6, 2009 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19327418
Resultados
1 -
16
de 16
1
Próxima >
>>